Side effects
Side effects as an overall problem
Side effects as an overall problem
Severity
Evaluations
Percentage
This item is relevant to you:
Severe
1
This item is relevant to you:
Moderate
0
This item is relevant to you:
Mild
5
This item is relevant to you:
None
9
Why patients stopped taking Omalizumab
Multiple reasons could be selected
Reason
Patients
Percentage
This item is relevant to you:
Did not seem to work
3
This item is relevant to you:
Expense
3
This item is relevant to you:
Course of treatment ended
2
This item is relevant to you:
Doctor's advice
2
This item is relevant to you:
Change in health plan coverage
1
This item is relevant to you:
Other
1
See
all
6 patients
who've
stopped taking Omalizumab
Duration
Stopped taking Omalizumab
Duration
Patients
Percentage
This item is relevant to you:
Less than 1 month
1
This item is relevant to you:
1 - 6 months
1
This item is relevant to you:
6 months - 1 year
1
This item is relevant to you:
1 - 2 years
2
This item is relevant to you:
2 - 5 years
1
Adherence
Adherence
Evaluations
Percentage
This item is relevant to you:
Always
14
14 evaluations from 13 patients
This item is relevant to you:
Usually
0
0 evaluations from 0 patients
This item is relevant to you:
Sometimes
0
0 evaluations from 0 patients
This item is relevant to you:
Never
taken as prescribed
1
1 evaluation from 1 patient
Burden
Burden
Evaluations
Percentage
This item is relevant to you:
Very
hard to take
2
2 evaluations from 2 patients
This item is relevant to you:
Somewhat
hard to take
4
4 evaluations from 4 patients
This item is relevant to you:
A little
hard to take
5
5 evaluations from 5 patients
This item is relevant to you:
Not at all
hard to take
4
4 evaluations from 4 patients
Cost per month
Cost per month
Evaluations
Percentage
This item is relevant to you:
$200+
3
3 evaluations from 2 patients
This item is relevant to you:
$100-199
0
0 evaluations from 0 patients
This item is relevant to you:
$50-99
1
1 evaluation from 1 patient
This item is relevant to you:
$25-49
4
4 evaluations from 4 patients
This item is relevant to you:
< $25
1
1 evaluation from 1 patient
This item is relevant to you:
Not specified
6
6 evaluations from 6 patients
What people switch to and from
Patients
started
taking
Omalizumab
after stopping:
Treatment
Patients
Percentage
This item is relevant to you:
Formoterol-mometasone
(Dulera )
1
Last updated:
April 26, 2026